U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07577479) titled 'A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants' on April 13.
Brief Summary: A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants
Study Start Date: May 15
Study Type: INTERVENTIONAL
Condition:
Healthy Participants Study
Intervention:
DRUG: BW-50218 Injection
Solution for injection
DRUG: Saline (0.9% NaCl)
Solution for injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....